Mostrar el registro sencillo del ítem
Vitamin C and folate status in hereditary fructose intolerance
dc.contributor.author | Cano, A. | |
dc.contributor.author | Alcalde, C. | |
dc.contributor.author | Belanger-Quintana, A. | |
dc.contributor.author | Cañedo-Villarroya, E. | |
dc.contributor.author | Ceberio, L. | |
dc.contributor.author | Chumillas-Calzada, S. | |
dc.contributor.author | Correcher, P. | |
dc.contributor.author | Couce Pico, María Luz | |
dc.contributor.author | García-Arenas, D. | |
dc.contributor.author | Gómez, I. | |
dc.contributor.author | Hernández, T. | |
dc.contributor.author | Izquierdo-García, E. | |
dc.contributor.author | Chicano, D.M. | |
dc.contributor.author | Morales, M. | |
dc.contributor.author | Pedrón-Giner, C. | |
dc.contributor.author | Jáuregui, E.P. | |
dc.contributor.author | Peña-Quintana, L. | |
dc.contributor.author | Sánchez Pintos, Paula | |
dc.contributor.author | Serrano-Nieto, J. | |
dc.contributor.author | Suarez, M.U. | |
dc.contributor.author | Miñana, I.V. | |
dc.contributor.author | de las Heras, J. | |
dc.date.accessioned | 2025-08-26T08:50:15Z | |
dc.date.available | 2025-08-26T08:50:15Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Cano A, Alcalde C, Belanger-Quintana A, Cañedo-Villarroya E, Ceberio L, Chumillas-Calzada S, et al. Vitamin C and folate status in hereditary fructose intolerance. European Journal of Clinical Nutrition. 2022;76(12):1733-9. | |
dc.identifier.issn | 1476-5640 | |
dc.identifier.other | https://portalcientifico.sergas.gal/documentos/62e5c2ede5f0e01a6a1d02fd | * |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/20624 | |
dc.description.abstract | Background: Hereditary fructose intolerance (HFI) is a rare inborn error of fructose metabolism caused by the deficiency of aldolase B. Since treatment consists of a fructose-, sucrose- and sorbitol-restrictive diet for life, patients are at risk of presenting vitamin deficiencies. Although there is no published data on the status of these vitamins in HFI patients, supplementation with vitamin C and folic acid is common. Therefore, the aim of this study was to assess vitamin C and folate status and supplementation practices in a nationwide cohort of HFI patients. Methods: Vitamin C and folic acid dietary intake, supplementation and circulating levels were assessed in 32 HFI patients and 32 age- and sex-matched healthy controls. Results: Most of the HFI participants presented vitamin C (96.7%) and folate (90%) dietary intake below the recommended population reference intake. Up to 69% received vitamin C and 50% folic acid supplementation. Among HFI patients, 15.6% presented vitamin C and 3.1% folate deficiency. The amount of vitamin C supplementation and plasma levels correlated positively (R = 0.443; p = 0.011). Interestingly, a higher percentage of non-supplemented HFI patients were vitamin C deficient when compared to supplemented HFI patients (30% vs. 9.1%; p = 0.01) and to healthy controls (30% vs. 3.1%; p < 0.001). Conclusions: Our results provide evidence for the first time supporting vitamin C supplementation in HFI. There is great heterogeneity in vitamin supplementation practices and, despite follow-up at specialised centres, vitamin C deficiency is common. Further research is warranted to establish optimal doses of vitamin C and the need for folic acid supplementation in HFI. | en |
dc.description.sponsorship | This work was supported by Exp. No. 2018111095, Basque Government, Health Department; FEDER, the Spanish Federation for Rare Diseases (FI18053); and DanoneNutricia-Metabolics, which was not involved in the study hypothesis/design, execution, analysis, or interpretation. | en |
dc.language.iso | eng | |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.title | Vitamin C and folate status in hereditary fructose intolerance | * |
dc.type | Article | en |
dc.authorsophos | Cano, J. A. | |
dc.authorsophos | Alcalde, C. | |
dc.authorsophos | Belanger-Quintana, A. | |
dc.authorsophos | Cañedo-Villarroya, E. | |
dc.authorsophos | Ceberio, L. | |
dc.authorsophos | Chumillas-Calzada, S. | |
dc.authorsophos | Correcher, P. | |
dc.authorsophos | Couce, M. L. | |
dc.authorsophos | García-Arenas, D. | |
dc.authorsophos | Gómez, I. | |
dc.authorsophos | Hernández, T. | |
dc.authorsophos | Izquierdo-García, E. | |
dc.authorsophos | Chicano, D. M. | |
dc.authorsophos | Morales, M. | |
dc.authorsophos | Pedrón-Giner, C. | |
dc.authorsophos | Jáuregui, E. P. | |
dc.authorsophos | Peña-Quintana, L. | |
dc.authorsophos | Sánchez-Pintos, P. | |
dc.authorsophos | Serrano-Nieto, J. | |
dc.authorsophos | Suarez, M. U. | |
dc.authorsophos | Miñana, I. V. | |
dc.authorsophos | de las, Heras | |
dc.identifier.doi | 10.1038/s41430-022-01178-3 | |
dc.identifier.sophos | 62e5c2ede5f0e01a6a1d02fd | |
dc.issue.number | 12 | |
dc.journal.title | European Journal of Clinical Nutrition | * |
dc.page.initial | 1733 | |
dc.page.final | 1739 | |
dc.relation.projectID | Basque Government, Health Department [2018111095]; FEDER, the Spanish Federation for Rare Diseases [FI18053] | |
dc.relation.publisherversion | https://www.nature.com/articles/s41430-022-01178-3.pdf | es |
dc.rights.accessRights | openAccess | |
dc.subject.keyword | AS Santiago | es |
dc.subject.keyword | CHUS | es |
dc.subject.keyword | IDIS | es |
dc.typefides | Artículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis) | es |
dc.typesophos | Artículo Original | es |
dc.volume.number | 76 |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
